Exactech Expands Presence in Japan

UltraSight Raises $13 million to Bring AI Guidance for Cardiac Ultrasound to Patient Point of Care

The Yozma Group Korea, Atain Specialty Insurance Company and the Weizmann Institute of Science participated in the round.

Jon Hopkins New Senior Vice President-Chief Development Officer of Legion Healthcare Partners

Over the past 23 years, Jon has held various positions at Varian Medical Systems including Director of Sales, Americas West & Latin America, Varian Proton Solutions and prior Director of Worldwide Sales, Varian Particle Therapy.

Sinan Batman Appointed CTO of TeraRecon

Batman brings rich industry experience to TeraRecon, including Chief Engineer at Carestream/Kodak Health Group, where he defined the vision for image-centric workflow information systems.

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, today announced that their company marked the first clinical use of recently approved shoulder, knee and hip replacement systems in Japan this quarter. These surgeries coincide with the series of new product introductions the company has reported in the U.S.

Exactech has gained regulatory approval to introduce additional products from each of its three major product segments to the Japanese market. The first Optetrak Logic® CR knee system was implanted on April 6 at Taketa Medical Association Hospital in Oita. The Novation® Crown Cup acetabular component debuted on April 26 in Ukubo City. The first Exactech total hip replacement surgery in Japan took place on May 16 at the Taketa Medical Association Hospital when a surgeon implanted the Alteon Tapered Wedge Stem along with the Crown Cup. The first Equinoxe Reverse Shoulder system was implanted June 5 at Sano Memorial Hospital.

Exactech Vice President of International Sales and Market Development Daniel Berdat said, “Exactech has maintained direct distribution in Japan since 2008 with consistent growth. These new product introductions are important milestones for Exactech in one of our key global markets.”  He concluded, “We are pleased to expand our offerings with these important innovations to better serve surgeons and patients.”

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles